ECMO support for COVID-19: a balancing act.
作者信息
Zhang Yang, Ji Bingyang, Zhou Zhou
机构信息
Department of Laboratory Medicine, National Center for Cardiovascular Diseases and Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100037, China.
Department of Cardiopulmonary Bypass, National Center for Cardiovascular Diseases and Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100037, China.
出版信息
Lancet. 2021 Jan 9;397(10269):94-95. doi: 10.1016/S0140-6736(20)32515-0.
Abstract
摘要
相似文献
1
ECMO support for COVID-19: a balancing act.体外膜肺氧合（ECMO）对新型冠状病毒肺炎（COVID-19）的支持：一项权衡之举。
Lancet. 2021 Jan 9;397(10269):94-95. doi: 10.1016/S0140-6736(20)32515-0.
2
ECMO support for COVID-19: a balancing act - Authors' reply.体外膜肺氧合（ECMO）对新型冠状病毒肺炎（COVID-19）的支持：权衡之举——作者回复
Lancet. 2021 Jan 9;397(10269):95. doi: 10.1016/S0140-6736(20)32517-4.
3
Thrombotic circuit complications during venovenous extracorporeal membrane oxygenation in COVID-19.COVID-19 患者行静脉-静脉体外膜肺氧合时的血栓性回路并发症。
J Thromb Thrombolysis. 2021 Feb;51(2):301-307. doi: 10.1007/s11239-020-02217-1.
4
Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series.COVID-19 患者体外膜肺氧合治疗期间并发神经破坏性脑实质内出血：病例系列研究。
Neurosurgery. 2020 Aug 1;87(2):E147-E151. doi: 10.1093/neuros/nyaa198.
5
Extracorporeal Membrane Oxygenation in COVID-19 Treatment: a Systematic Literature Review.COVID-19 治疗中的体外膜肺氧合：系统文献回顾。
Braz J Cardiovasc Surg. 2021 Jun 1;36(3):388-396. doi: 10.21470/1678-9741-2020-0397.
6
Recommendations for extracorporeal membrane oxygenation (ECMO) in COVID-19 patients : Consensus paper of the Medical University of Vienna.关于 COVID-19 患者体外膜肺氧合（ECMO）的建议：维也纳医科大学共识文件。
Wien Klin Wochenschr. 2020 Nov;132(21-22):671-676. doi: 10.1007/s00508-020-01708-8. Epub 2020 Jul 3.
7
Inflammatory Response Assessment in Patients with COVID-19 Under Extracorporeal Membrane Oxygenation Support.接受体外膜肺氧合支持的新型冠状病毒肺炎患者的炎症反应评估
Clin Lab. 2021 May 1;67(5). doi: 10.7754/Clin.Lab.2020.200916.
8
Acute Respiratory Distress Syndrome Treated With Awake Extracorporeal Membrane Oxygenation in a Patient With COVID-19 Pneumonia.清醒体外膜肺氧合治疗新型冠状病毒肺炎所致急性呼吸窘迫综合征1例
J Cardiothorac Vasc Anesth. 2021 Aug;35(8):2467-2470. doi: 10.1053/j.jvca.2020.11.017. Epub 2020 Nov 10.
9
Selecting candidates for veno-venous ECMO during COVID-19 pandemic: the importance of an ECMO team.在新冠疫情期间选择静脉-静脉体外膜肺氧合（ECMO）治疗的候选人：ECMO团队的重要性
Perfusion. 2021 Sep;36(6):640-642. doi: 10.1177/02676591211005705. Epub 2021 Mar 24.
10
Pregnant and Peripartum Women with COVID-19 Have High Survival with Extracorporeal Membrane Oxygenation: An Extracorporeal Life Support Organization Registry Analysis.患有新冠肺炎的孕妇和围产期妇女接受体外膜肺氧合治疗后生存率较高：体外生命支持组织注册分析
Am J Respir Crit Care Med. 2022 Jan 15;205(2):248-250. doi: 10.1164/rccm.202109-2096LE.
引用本文的文献
1
Multi-modal prediction of extracorporeal support-a resource intensive therapy, utilizing a large national database.利用大型国家数据库对体外支持（一种资源密集型治疗）进行多模态预测。
JAMIA Open. 2025 Jan 6;8(1):ooae158. doi: 10.1093/jamiaopen/ooae158. eCollection 2025 Feb.
2
Neutrophils: a key component in ECMO-related acute organ injury.中性粒细胞：ECMO 相关急性器官损伤的关键组成部分。
Front Immunol. 2024 Sep 13;15:1432018. doi: 10.3389/fimmu.2024.1432018. eCollection 2024.
3
Artificial Intelligence in Intensive Care Medicine: Toward a ChatGPT/GPT-4 Way?人工智能在重症医学中的应用：迈向 ChatGPT/GPT-4 之路？
Ann Biomed Eng. 2023 Sep;51(9):1898-1903. doi: 10.1007/s10439-023-03234-w. Epub 2023 May 13.
4
Association of COVID-19 with Intracranial Hemorrhage during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: A 10-Year Retrospective Observational Study.新型冠状病毒肺炎与急性呼吸窘迫综合征体外膜肺氧合期间颅内出血的关联：一项10年回顾性观察研究
J Clin Med. 2021 Dec 22;11(1):28. doi: 10.3390/jcm11010028.
5
Research Progress in the Treatment of Complications and Sequelae of COVID-19.新型冠状病毒肺炎并发症及后遗症的治疗研究进展
Front Med (Lausanne). 2021 Dec 2;8:757605. doi: 10.3389/fmed.2021.757605. eCollection 2021.
6
A comprehensive review of vascular complications in COVID-19.关于 COVID-19 血管并发症的全面综述。
J Thromb Thrombolysis. 2022 Apr;53(3):586-593. doi: 10.1007/s11239-021-02593-2. Epub 2021 Nov 1.
本文引用的文献
1
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry.COVID-19 患者的体外膜肺氧合支持：体外生命支持组织登记处的国际队列研究。
Lancet. 2020 Oct 10;396(10257):1071-1078. doi: 10.1016/S0140-6736(20)32008-0. Epub 2020 Sep 25.
2
Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring.COVID-19 住院患者的血栓风险预防和止血监测。
Crit Care. 2020 Jun 19;24(1):364. doi: 10.1186/s13054-020-03000-7.
3
Coagulation abnormalities and thrombosis in patients with COVID-19.新型冠状病毒肺炎患者的凝血异常与血栓形成
Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.
4
COVID-19 and its implications for thrombosis and anticoagulation.新型冠状病毒肺炎及其对血栓形成和抗凝的影响。
Blood. 2020 Jun 4;135(23):2033-2040. doi: 10.1182/blood.2020006000.
5
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
Zotero 插件